Citation Impact
Citing Papers
Diabetes and Cardiovascular Disease
1999 Standout
Exercise Training and the Cardiovascular Consequences of Type 2 Diabetes and Hypertension
2002
In situ study of myofibrils, mitochondria and bound creatine kinases in experimental cardiomyopathies
1994
Carnitine transport and exogenous palmitate oxidation in chronically volume-overloaded rat hearts
1989
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Intracellular pH regulation in heart
2008
Role of malonyl-CoA in heart disease and the hypothalamic control of obesity
2006
Skeletal Muscle Fatigue: Cellular Mechanisms
2008 Standout
Long-term therapy with trimetazidine in cardiomyopathic Syrian hamster BIO 14:6
1997
Verapamil attenuates ATP depletion during hypoxia: 31P NMR studies of the isolated rat heart
1989
Regulation of the activity of caspases by L ‐carnitine and palmitoylcarnitine
2000
What Do We Know and We Do Not Know About Cardiovascular Autonomic Neuropathy in Diabetes
2012
Marine natural products
1990 Standout
β-Arrestin 1 and Gαq/11 Coordinately Activate RhoA and Stress Fiber Formation following Receptor Stimulation
2004 StandoutNobel
Myocardial ischemia-reperfusion injury: a neglected therapeutic target
2013 Standout
Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure
2006
Na+/h+exchange inhibitors for cardioprotective therapy: progress, problems and prospects
2002
Na+ accumulation increases Ca2+ overload and impairs function in anoxic rat heart,
1990
Influence of Diabetes Mellitus on Clinical Outcome in the Thrombolytic Era of Acute Myocardial Infarction fn1fn1The GUSTO-I study was supported by a combined grant from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genetech, South San Francisco, California; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.
1997
Reversible Ultrastructural Alterations in the Myocytic Mitochondria of Isolated Rat Hearts Induced by Oxygen Radicals
1997
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Role of nitric oxide, tetrahydrobiopterin and peroxynitrite in glucose toxicity-associated contractile dysfunction in ventricular myocytes
2003
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Effects of L-carnitine and its derivatives on postischemic cardiac function, ventricular fibrillation and necrotic and apoptotic cardiomyocyte death in isolated rat hearts
2003
The fate of arachidonic acid and linoleic acid in isolated working rat hearts containing normal or elevated levels of coenzyme A
1991
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Diabetes and Atherosclerosis
2002 Standout
Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and Postconditioning
2007
Energy Metabolism After Ischemic Preconditioning in Streptozotocin-Induced Diabetic Rat Hearts
1998
Diabetic cardiomyopathy: recent evidence from mouse models of type 1 and type 2 diabetes
2004
Striking Differences Between the Kinetics of Regulation of Respiration by ADP in Slow‐Twitch and Fast‐Twitch Muscles In Vivo
1996
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Influence of Trimetazidine on the synthesis of complex lipids in the heart and other target organs
2001
Role of controlled cardiac reoxygenation in reducing nitric oxide production and cardiac oxidant damage in cyanotic infantile hearts.
1994 StandoutNobel
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Myocardial Reperfusion Injury
2007 Standout
Regulation of energy substrate metabolism in the diabetic heart
1997
Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine
2006
Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy
2003
The ChEMBL database in 2017
2016 Standout
Biochemistry and molecular cell biology of diabetic complications
2001 StandoutNature
Trimetazidine increases phosppholipid turnover in ventricular myocyte
1997
A Randomized Clinical Trial of Trimetazidine, a Partial Free Fatty Acid Oxidation Inhibitor, in Patients With Heart Failure
2006
Sensors and regulators of intracellular pH
2009 Standout
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Glucose oxidation is stimulated in reperfused ischemic hearts with the carnitine palmitoyltransferase 1 inhibitor, Etomoxir
1989
Cardiovascular effects of lepadiformine, an alkaloid isolated from the ascidians Clavelina lepadiformis (Müller) and C. moluccensis (Sluiter)
2001
Trimetazidine Normalizes Postischemic Function of Hypertrophied Rat Hearts
2005
Role of changes in cardiac metabolism in development of diabetic cardiomyopathy
2006
Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways
2014
Pharmacological Prevention of Atrial Tachycardia Induced Atrial Remodeling as a Potential Therapeutic Strategy
2003
High levels of fatty acids delay the recoveryof intracellular pH and cardiac efficiency inpost-ischemic hearts by inhibiting glucose oxidation
2002
Glucose oxidation rates in fatty acid-perfused isolated working hearts from diabetic rats
1989
Regulation of fatty acid oxidation in the mammalian heart in health and disease
1994
Mitochondrial membrane potential in cardiac myocytes
2002
High-Glucose Stimulation Increases Reactive Oxygen Species Production Through the Calcium and Mitogen-Activated Protein Kinase-Mediated Activation of Mitochondrial Fission
2010
Physiology and Pathophysiology of Carnosine
2013 Standout
Fibrosis, not cell size, delineates β-myosin heavy chain reexpression during cardiac hypertrophy and normal aging in vivo
2006 StandoutNobel
In situ study of myofibrils, mitochondria and bound creatine kinases in experimental cardiomyopathies
1994
Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus
2005 Standout
Age-Dependent Changes in Metabolism, Contractile Function, and Ischemic Sensitivity in Hearts From db/db Mice
2003
Oxidative Stress, Prooxidants, and Antioxidants: The Interplay
2014 Standout
The Na+/H+ exchanger: an update on structure, regulation and cardiac physiology
1993
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy
2008 Standout
Activation of glomerular mitogen-activated protein kinases in angiotensin II-mediated hypertension.
1998 StandoutNobel
Ketone bodies disturb fatty acid handling in isolated cardiomyocytes derived from control and diabetic rats
2003
Effect of estrogen on global myocardial ischemia-reperfusion injury in female rats
2000 StandoutNobel
Characteristics of Diabetes, Blood Pressure, and Cardiac and Renal Complications in Otsuka Long-Evans Tokushima Fatty Rats
1997
Electrostimulation enhances FAT/CD36-mediated long-chain fatty acid uptake by isolated rat cardiac myocytes
2001
Reversibility of diabetic cardiomyopathy with insulin in rats.
1981
In vitro study on contribution of oxidative metabolism of isolated rabbit heart mitochondria to myocardial reperfusion injury.
1984
Carnitine Palmitoyltransferase (CPT) Modulators: A Medicinal Chemistry Perspective on 35 Years of Research
2011
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Diabetic Cardiomyopathy
2018 Standout
Diabetes mellitus and cardiac function
1998
Palmitate oxidation by the mitochondria from volume-overloaded rat hearts
1998
The oxygen paradox and the calcium paradox: Two facets of the same problem?
1978
Oxidative Stress and Diabetic Complications
2010 Standout
Etomoxir, a carnitine palmitoyltransferase I inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine.
1988
Superoxide dismutase plus catalase enhances the efficacy of hypothermic cardioplegia to protect the globally ischemic, reperfused heart
1982
Alteration of the cytosolic-mitochondrial distribution of high-energy phosphates during global myocardial ischemia may contribute to early contractile failure.
1994
Fiber Types in Mammalian Skeletal Muscles
2011 Standout
Diabetes mellitus and cardiac function
1998
Role of calcium in triggering rapid ultrastructural damage in muscle: a study with chemically skinned fibres
1987
Overexpression of Metallothionein Reduces Diabetic Cardiomyopathy
2002
Rosiglitazone Treatment in Zucker Diabetic Fatty Rats Is Associated With Ameliorated Cardiac Insulin Resistance and Protection From Ischemia/Reperfusion-Induced Myocardial Injury
2005
Hyperglycemic Pseudohypoxia and Diabetic Complications
1993
Myocardial insulin resistance, metabolic stress and autophagy in diabetes
2012
Role of mitochondrial calcium transport in the control of substrate oxidation
1998
Oxygen Radicals and Human Disease
1987 Standout
Role of mitochondrial calcium transport in the control of substrate oxidation
1998
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
1999 Standout
Substrate proteins for calmodulin-sensitive and phospholipid-sensitive Ca2+-dependent protein kinases in heart, and inhibition of their phosphorylation by palmitoylcarnitine.
1981
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
Mechanisms of Diabetic Complications
2013 Standout
Palmitate oxidation by the mitochondria from volume-overloaded rat hearts
1998
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Diabetic Cardiomyopathy Revisited
2007
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
2018 Standout
Fourth universal definition of myocardial infarction (2018)
2018 Standout
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Advanced Glycation End Products and Diabetic Complications
2014
Postnatal development of palmitate oxidation and mitochondrial enzyme activities in rat cardiac and skeletal muscle
1982
Alterations in Ca2+ binding by and composition of the cardiac sarcolemmal membrane in chronic diabetes.
1983
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
2008 Standout
Production of Reactive Oxygen Species in the Diabetic Heart
2013
Functional Significance of Cell Volume Regulatory Mechanisms
1998 Standout
Molecular Mechanisms of Myocardial Remodeling
1999 Standout
The additive protective effects of hypothermia and chemical cardioplegia during ischemic cardiac arrest in the rat
1980
Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases
2000
Adenovirus-Mediated Overexpression of O -GlcNAcase Improves Contractile Function in the Diabetic Heart
2005
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
Pathobiology of acute myocardial ischemia: Metabolic, functional and ultrastructural studies
1983
Prevention Conference VI: Diabetes and Cardiovascular Disease
2002
Sodium/Calcium Exchange: Its Physiological Implications
1999 Standout
Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure
2000 Standout
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Angiotensin Blockade Improves Cardiac and Renal Complications of Type II Diabetic Rats
1997 StandoutNobel
Creatine and Creatinine Metabolism
2000 Standout
The additive protective effects of hypothermia and chemical cardioplegia during ischemic cardiac arrest in the dog
1980
Oxygen-Derived Free Radicals in Postischemic Tissue Injury
1985 Standout
Diabetes and mitochondrial oxidative stress: A study using heart mitochondria from the diabetic Goto-Kakizaki rat
2003
Protein kinase C phosphorylates the inhibitory guanine‐nucleotide‐binding regulatory component and apparently suppresses its function in hormonal inhibition of adenylate cyclase
1985 StandoutNobel
The oxygen free radical system: A fundamental mechanism in the production of myocardial necrosis
1986
Cardiac performance during reperfusion improved by pretreatment with oxygen free-radical scavengers
1986
Works of D. Feuvray being referenced
[Protective effect of endogenous catecholamine depletion against hypoxic and reoxygenation damage in isolated rat heart: an ultrastructural study (author's transl)].
1980
Diltiazem protects the isolated rabbit heart from the mechanical and ultrastructural damage produced by transient hypoxia, low-flow ischemia and exposure to Ca++-free medium.
1983
Intracellular pH and role of Na+/H+ exchange during ischaemia and reperfusion of normal and diabetic rat hearts
1990
Controversies on the sensitivity of the diabetic heart to ischemic injury: the sensitivity of the diabetic heart to ischemic injury is decreased
1997
Effects of trimetazidine on pHi regulation in the rat isolated ventricular myocyte
1996
Calcium and potassium currents in ventricular myocytes isolated from diabetic rats.
1993
High glucose-induced apoptosis through store-operated calcium entry and calcineurin in human umbilical vein endothelial cells
2005
Diabetes-related metabolic perturbations in cardiac myocyte
2008
Skinned cardiac fibres of diabetic rats: contractile activation and effects of 2,3-butanedione monoxime (BDM) and caffeine
1993
Enhanced activity of the myocardial Na+/H+ exchanger contributes to left ventricular hypertrophy in the Goto–Kakizaki rat model of type 2 diabetes: critical role of Akt
2007
HCO 3 − -dependent alkalinizing transporter in adult rat ventricular myocytes: characterization and modulation
1997
Structural, functional, and metabolic correlates in ischemic hearts: effects of substrates
1981
Mechanisms of intracellular pH regulation during postischemic reperfusion of diabetic rat hearts
1995
Altered Ca2+ handling in ventricular myocytes isolated from diabetic rats
1996
Factors affecting the release of lactate dehydrogenase from isolated rat heart after calcium and magnesium free perfusions
1973
Relationship between structure and fatty acid metabolism in mitochondria isolated from ischemic rat hearts.
1981
Reduction of Ischemia-Induced Acyl Carnitine Accumulation by TDGA and Its Influence on Lactate Dehydrogenase Release in Diabetic Rat Hearts
1986
Protection of the ischemic myocardium
1978
Effects of ischemia on rat myocardial function and metabolism in diabetes.
1979
The ERK pathway regulates Na+-HCO 3 − cotransport activity in adult rat cardiomyocytes
2002
Electrophysiological analysis of the sensitivity to calcium in ventricular muscle from alloxan diabetic rats
1986
Modulation by pHoand Intracellular Ca2+of Na+-H+Exchange in Diabetic Rat Isolated Ventricular Myocytes
1997
Different pathways for sodium entry in cardiac cells during ischemia and early reperfusion
2003
Mechanisms of Intracellular pH Regulation During Postischemic Reperfusion of Diabetic Rat Hearts
1995
Ultrastructural modifications induced by reoxygenation in the anoxic isolated rat heart perfused without exogenous substrate
1975
Ionic and metabolic imbalance as potential factors of ischemia reperfusion injury
1998
Lipid intermediates in chronically volume-overloaded rat hearts
1984
Reduction of ischemia-induced acyl carnitine accumulation by TDGA and its influence on lactate dehydrogenase release in diabetic rat hearts
1986
Metabolic products and myocardial ischemia.
1981